Danmeng Huang

1PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 20, 2026
Cost-effectiveness of pembrolizumab plus chemotherapy vs cemiplimab plus chemotherapy for first-line metastatic non-small cell lung cancer: a US payer perspective using a matching-adjusted indirect comparison.

Danmeng Huang, Ying Zhang, Riddhi A Babel

Pageof 1

Frequent Collaborators

1 joint publications

Riddhi A Babel

1 joint publications

Mayur M Amonkar